Page last updated: 2024-08-24

ibandronic acid and pyridinoline

ibandronic acid has been researched along with pyridinoline in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Schlosser, K; Scigalla, P	1
Grauer, A; Heichel, S; Oberwittler, H; Seibel, MJ; Woitge, HW; Ziegler, R	1
Hommann, M; Kaemmerer, D; Lehmann, G; Schmidt, B; Settmacher, U; Wolf, G	1

Trials

2 trial(s) available for ibandronic acid and pyridinoline

Article	Year
Biochemical markers as surrogates in clinical trials in patients with metastatic bone disease and osteoporosis. Scandinavian journal of clinical and laboratory investigation. Supplementum, 1997, Volume: 227 Topics: Absorptiometry, Photon; Administration, Oral; Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Resorption; Calcitriol; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ibandronic Acid; Injections, Intravenous; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Placebos; Procollagen	1997
Short- and long-term effects of ibandronate treatment on bone turnover in Paget disease of bone. Clinical chemistry, 2000, Volume: 46, Issue:5 Topics: Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Chromatography, High Pressure Liquid; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Female; Humans; Ibandronic Acid; Integrin-Binding Sialoprotein; Male; Middle Aged; Osteitis Deformans; Osteocalcin; Prospective Studies; Radioimmunoassay; Sialoglycoproteins	2000

Article

Year

Biochemical markers as surrogates in clinical trials in patients with metastatic bone disease and osteoporosis.

Scandinavian journal of clinical and laboratory investigation. Supplementum, 1997, Volume: 227

Topics: Absorptiometry, Photon; Administration, Oral; Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Resorption; Calcitriol; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ibandronic Acid; Injections, Intravenous; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Placebos; Procollagen

1997

Short- and long-term effects of ibandronate treatment on bone turnover in Paget disease of bone.

Clinical chemistry, 2000, Volume: 46, Issue:5

Topics: Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Chromatography, High Pressure Liquid; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Female; Humans; Ibandronic Acid; Integrin-Binding Sialoprotein; Male; Middle Aged; Osteitis Deformans; Osteocalcin; Prospective Studies; Radioimmunoassay; Sialoglycoproteins

2000

Other Studies

1 other study(ies) available for ibandronic acid and pyridinoline

Article	Year
Monthly ibandronate for the prevention of bone loss in patients after liver transplantation. Transplantation proceedings, 2012, Volume: 44, Issue:5 Topics: Absorptiometry, Photon; Administration, Oral; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Chi-Square Distribution; Cholecalciferol; Creatinine; Dietary Supplements; Diphosphonates; Drug Administration Schedule; Femur Neck; Fractures, Bone; Germany; Humans; Ibandronic Acid; Liver Transplantation; Lumbar Vertebrae; Osteoporosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2012

Article

Year

Monthly ibandronate for the prevention of bone loss in patients after liver transplantation.

Transplantation proceedings, 2012, Volume: 44, Issue:5

Topics: Absorptiometry, Photon; Administration, Oral; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Chi-Square Distribution; Cholecalciferol; Creatinine; Dietary Supplements; Diphosphonates; Drug Administration Schedule; Femur Neck; Fractures, Bone; Germany; Humans; Ibandronic Acid; Liver Transplantation; Lumbar Vertebrae; Osteoporosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

2012